COMPAT has upheld order of CCI whereby it declined to order an investigation into the allegations of abuse of dominance by Vodafone India for levying exorbitant charges for international roaming plan.

Almost six years after the enactment of the Competition Act 2002 (“Competition Act”), India’s competition regulator - the Competition Commission of India (CCI) has finally become operational.

The CESTAT Mumbai has clarified the customs classification dispute surrounding glucometers, determining whether these portable blood glucose measurement devices belong under medical instruments or chemical analysis apparatus in the Customs Tariff Act, 1975. The Tribunal's decision hinges on the fundamental operational principle of glucometers and establishes important precedent for classifying devices that serve both analytical and medical purposes.

The Competition Commission of India has recently amended the CCI Regulations, 2011 easing norms for certain M&A activity.

The CCI directed the Director General to investigate Mahyco Monsanto Biotech (I) Limited, Monsanto Holdings Private Ltd., Monsanto Inc., U.S.A. and Maharashtra Hybrid Seeds Company Ltd.

On 4 March 2011, the Indian Government brought into force the provisions of the Competition Act 2002 (the 'Act') relating to the regulation of mergers.

After a decade-long investigation into allegations of anti-competitive practices in Delhi's hospital sector, India's Competition Commission has delivered a landmark ruling on aftermarket abuse and excessive pricing. The case, which began with complaints about disposable syringe markups at Max Super Specialty Hospital, evolved into a comprehensive examination of pricing practices across 12 super specialty hospitals, ultimately establishing critical precedents for defining healthcare aftermarkets and applying

The Competition Commission of India (Lesser Penalty) Regulations, 2009 (Leniency Regulations) have been amended by a notification issued on 22 August 2017 (Notification).

India's Directorate General of Trade Remedies has launched an anti-dumping investigation into Cold Rolled Grain Oriented Electrical Steel and Amorphous Metal imports from Japan, China, Korea, and Russia. This investigation carries significant implications for Japanese steel producers and exporters, particularly given Japan's leadership in manufacturing premium grain-oriented electrical steel and India's growing demand for transformer-grade materials. The notification raises critical questions about product

The CCI, in line with its decisional practice, held that it was first necessary to delineate the relevant market and ascertain whether the Merlin Group enjoyed a dominant position.

A generic manufacturer spends virtually nothing on R&D, does not mean that without effort generics can be marketed. It actually requires the demonstration of safety and effect of the product by the innovator to the regulator for approval.

Accordingly, CDAB, Gujarat Federation and their office bearers have been directed to cease and desist from indulging in the aforesaid anti-competitive practices.

The Competition Commission of India (CCI) notified the Competition Commission of India (Procedure in regard to the transaction of business relating to combinations) Amendment Regulations, 2018 on 9 October 2018 (Amendment Regulations).

CCI, pursuant to its power under Section 26 (1) of Act has initiated an investigation against Mahyco Monsanto Biotech (India) Limited and its sister concerns for alleged contraventions of Sections 3 and 4 of the Act.

2016 witnessed a new entrant in the Telecom market! Jio, which not only came up with jaw dropping customer friendly offers which were not appreciated by its competitors.

It creates efficient and glowing atmosphere everywhere.

The ambit of the Monopolies & Restrictive Trade Practices Act, 1969 was found to be inadequate for fostering competition in the market and eliminating anti-competitive practices in the national and international trade.

Pursuant to the suggestions made by the inter-ministerial committee on data protection headed by Satwant Reddy, former chemicals secretary, the ministries of health and agriculture, in a recent meeting, decided to initiate action to bring amendments inserting data protection clauses in the Drugs and Cosmetics Act, 1940 and Insecticides Act, 1968

In an attempt to further streamline the merger control process, the Competition Commission of India has for the sixth time since the introduction of the merger control regime in India, amended the ...

The CCI by its recent order dated February 25, 2016 has closed the complaint filed by Prasar Bharti against the television audience measurement services agency, TAM Media Research Private Limited.